Chinese startup NeuroXess' new BCI can decipher the complex Chinese language in brain, operate a robotic arm and interact with AI.

SHANGHAI -- Chinese startup NeuroXess on Thursday reported two significant clinical-trial milestones: its flexible ...

Chinese startup NeuroXess on Thursday reported two significant clinical-trial milestones its flexible brain-computer interface BCI device successfu ...

Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who ...

The real-world effectiveness of Monjuvi for relapsed or refractory diffuse large B-cell lymphoma in the U.S. was demonstrated ...

With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will ...

Fenske, MD led ECOG-ACRIN EA4151, the first randomized trial to compare treatment with or without stem cell transplant in patients with MRD-negative mantle cell lymphoma in first complete remission.

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announces new appointments of cancer researchers to lead committees in its expansive scientific program. ECOG-ACRIN is at the forefront of ...